Artificial intelligence (AI) is changing healthcare in the United States quickly. AI tools are used in everyday clinical work, from early diagnosis to critical care. But, while AI can help, it also brings new problems. One big problem is how to find out if AI really helps patients and if it saves money. This is where health economists come in. They check if AI really improves care and lowers costs.
People who run medical practices and hospitals, and IT managers, need to understand how much AI is worth and how well it works. Choosing to use AI tools needs to be based on good data and economic studies. This makes sure healthcare gets better without causing problems.
AI in healthcare is not the same as usual medical tools like drugs or devices. AI systems keep learning by collecting complex data and need ongoing training to work well. Usual methods to test medical tools were made for one-time checks, not for AI that keeps changing.
Health economists in the U.S. face many challenges when checking clinical AI:
Because of these reasons, checking AI’s value needs new economic methods and many ways to test. Health economists must look at both short-term and long-term effects on healthcare and costs.
One way to check AI in U.S. healthcare is by studying AI used in intensive care units (ICUs). These units care for patients who need machines to help with breathing. These patients need a lot of care and resources.
Researchers made a health-economic model that mimics what happens to patients from when they enter the hospital until death. This model compares normal care to care helped by AI. It helps guess if AI is cost-effective in different ICU cases. The model can be changed to fit different ICU situations in the U.S.
The model looks at things like how long patients stay, how many resources are used, and survival. It helps know if AI can save money and improve results. This early assessment gives hospital leaders useful advice on how to price AI, plan clinical studies, and choose patients who might benefit most.
This work is important because it helps hospitals decide before there is a lot of clinical data. It helps them avoid spending money on AI that may not be helpful.
AI can be used in many ways in healthcare. Each way needs different types of assessment:
AI depends a lot on big sets of data and training. Health economists check these parts carefully because the quality of data and learning methods affect how useful AI is in care and cost.
This deep review helps healthcare groups make good choices about investing in AI that fits their goals and patients’ needs.
AI automation is not just for clinical help. It also affects daily hospital admin work.
Simbo AI is a company that makes AI systems to handle front-office phone work. These tools can help medical practices and hospitals in the U.S. Their AI handles patient calls, booking appointments, and answering questions. This lowers the load on admin staff. It helps patients reach services better and lets staff do more difficult work that needs human decisions.
Automation here can improve workflow by:
But the AI must be set up carefully. Poor setup can increase workload if staff fix AI mistakes or follow up on automated tasks. Health economists study these effects by comparing productivity improvements with any extra work or errors. This gives useful information to managers and IT staff.
Automation should help, not replace, human skills. Health economists and leaders must make sure workflows keep quality checks and that AI fits well without hurting patient-doctor interactions or admin oversight.
One worry about using AI in U.S. healthcare is making health differences worse for underserved groups. AI trained on biased data or without enough diverse patients might give unfair or less correct results.
On the other hand, if designed right, AI can help health equity by:
Health economists check how AI might affect equity by studying results for different groups and seeing if AI helps or harms health fairness.
Agencies like the U.S. Food and Drug Administration (FDA) are more involved in overseeing AI medical tools. Because AI is different from usual devices, they focus on ongoing safety checks to reduce risks like overuse or losing skills.
Health economists help by including these regulatory rules and costs in economic models. They also consider costs for following rules and watching AI after it comes into use.
For healthcare managers and IT teams in the U.S. thinking about using AI:
AI can help improve healthcare in the United States in many ways, from urgent care to admin tasks. Health economists offer needed help to assess AI’s clinical, operational, and cost effects. Their work supports smart choices for healthcare leaders who want to use AI responsibly and within budget. As healthcare changes, using economic studies and ongoing checks will help make sure AI delivers help without causing big problems.
Medical practice managers, healthcare owners, and IT staff should work closely with health economists and AI providers—like Simbo AI—when planning AI use. This cooperation helps balance new technology with practical needs important for lasting healthcare service.
The objectives include evaluating the traditional health technology assessment methods and emphasizing the need to understand AI’s value in terms of health outcomes and costs.
Challenges include unclear generalizability across populations and the need to reconfigure clinical processes, which can complicate the measurement of core value elements.
AI can enhance clinician productivity by automating certain tasks, allowing for more efficient workflows, though improper implementation may lead to increased workloads.
Poorly implemented AI may exacerbate health disparities or increase clinicians’ workloads, resulting in unintended negative impacts on healthcare delivery.
AI can expand access to medical care and, with proper training, provide unbiased diagnoses and prognoses, potentially reducing disparities.
Assessments should vary based on the case of AI use, such as creating new clinical possibilities or automating processes, each requiring different evaluation criteria.
While AI can improve productivity, it may also reduce clinicians’ skill sets as automation takes over specific tasks and procedures.
Health economists should examine data collection methods and training processes for AI, as these factors influence the technology’s future value.
AI presents significant opportunities and challenges for healthcare delivery, necessitating adapted assessment frameworks and careful implementation to ensure value.
Regulation is necessary to ensure that AI applications are safe, effective, and equitable, addressing concerns such as overuse and impact on healthcare disparities.